Ana I. Robles

Research interests

Publications

• Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation

  Cell · 2023 · https://doi.org/10.1016/j.cell.2023.07.013

• Proteogenomic data and resources for pan-cancer analysis

  Cancer Cell · 2023 · https://doi.org/10.1016/j.ccell.2023.06.009

• Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness

  Cancer Cell · 2022 · https://doi.org/10.1016/j.ccell.2022.12.001

• Proteogenomic characterization of pancreatic ductal adenocarcinoma

  Cell · 2021 · https://doi.org/10.1016/j.cell.2021.08.023

• A proteogenomic portrait of lung squamous cell carcinoma

  Cell · 2021 · https://doi.org/10.1016/j.cell.2021.07.016

• Proteogenomic and metabolomic characterization of human glioblastoma

  Cancer Cell · 2021 · https://doi.org/10.1016/j.ccell.2021.01.006

• Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma

  Cancer Cell · 2021 · https://doi.org/10.1016/j.ccell.2020.12.007

• Proteogenomics of Non-smoking Lung Cancer in East Asia Delineates Molecular Signatures of Pathogenesis and Progression

  Cell · 2020 · https://doi.org/10.1016/j.cell.2020.06.012

• Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma

  Cell · 2020 · https://doi.org/10.1016/j.cell.2020.06.013

• Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy

  Cell · 2020 · 10.1016/j.cell.2020.10.036

• Proteogenomic Characterization of Endometrial Carcinoma

  Cell · 2020 · https://doi.org/10.1016/j.cell.2020.01.026

• Integrated Proteogenomic Characterization across Major Histological Types of Pediatric Brain Cancer

  Cell · 2020 · https://doi.org/10.1016/j.cell.2020.10.044

• Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma

  Cell · 2019 · https://doi.org/10.1016/j.cell.2019.08.052

• Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma

  Cell · 2019 · https://doi.org/10.1016/j.cell.2019.10.007

• Interaction between the microbiome and TP53 in human lung cancer

  Genome biology · 2018 · https://doi.org/10.1186/s13059-018-1501-6

• Mutant p53 cancers reprogram macrophages to tumor supporting macrophages via exosomal miR-1246

  Nature Communications · 2018 · https://doi.org/10.1038/s41467-018-03224-w

• Whole-Exome Sequencing Analyses of Inflammatory Bowel Disease−Associated Colorectal Cancers

  Gastroenterology · 2016 · https://doi.org/10.1053/j.gastro.2015.12.036

• Genetic variation in microRNA networks: the implications for cancer research

  Nature reviews. Cancer · 2010 · https://doi.org/10.1038/nrc2867

• Hsp90 inhibitor PU-H71, a multimodal inhibitor of malignancy, induces complete responses in triple-negative breast cancer models

  Proceedings of the National Academy of Sciences · 2009 · https://doi.org/10.1073/pnas.0903392106

• Clinical Outcomes and Correlates of TP53 Mutations and Cancer

  Cold Spring Harbor Perspectives in Biology · 2009 · https://doi.org/10.1101/cshperspect.a001016

• p53-Induced Up-Regulation of MnSOD and GPx but not Catalase Increases Oxidative Stress and Apoptosis

  Cancer Research · 2004 · https://doi.org/10.1158/0008-5472.can-2287-2

• Predicting hepatitis B virus–positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning

  Nature Medicine · 2003 · https://doi.org/10.1038/nm843

• Reduced skin tumor development in cyclin D1-deficient mice highlights the oncogenic ras pathway in vivo

  Genes & Development · 1998 · https://doi.org/10.1101/gad.12.16.2469

• Induction of cyclin D1 overexpression by activated ras.

  PubMed · 1994

Current projects

No projects listed.